Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:13 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2 / Phase 3CompletedINTERVENTIONAL

Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

ClinicalTrials.gov · NCT02271360 · Registry updated: 2017-02-16

Condition / research focus: Infertility
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-04. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Dobesilate (drug) — also listed as: doxium
Cabergoline (drug) — also listed as: Dostinex

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Benha univesity hospital
Banhā, El Qualyobia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome

ClinicalTrials.gov · NCT02290002 · Registry updated: 2017-02-14

Condition / research focus: Infertility
Sponsor: khalid abd aziz mohamed
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-06. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Dobesilate (drug) — also listed as: doxium
coasting (other)

Where the study takes place — 1 listed sites

Benha univesity hospital
Banhā, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Human Chorionic Gonadotrophin & Trigger

ClinicalTrials.gov · NCT02264847 · Registry updated: 2017-02-08

Condition / research focus: Ovulation Disorder
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-10. Completion: 2017-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotrophin (drug) — also listed as: hCG
clomiphene citrate alone (drug)

Where the study takes place — 1 listed sites

faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Timing Progesterone Luteal Support on Embryo Transfer

ClinicalTrials.gov · NCT03040830 · Registry updated: 2017-02-02

Condition / research focus: Progesterone Luteal Support in ICSI; Embryo Transfer
Sponsor: Mansoura Integrated Fertility Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-11-01. Completion: 2017-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Progesterone 100 IM/day (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies

ClinicalTrials.gov · NCT01608347 · Registry updated: 2017-01-24

Condition / research focus: Recurrent Miscarriage
Sponsor: Omar Mamdouh Shaaban
Countries with listed sites: No country reported
Registry dates and results: Start: 2010-01. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LMWH+Folic acid (drug) — also listed as: (Clexane, Sanofi Aventis, Paris, France)
Folic Acid (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder

ClinicalTrials.gov · NCT03027843 · Registry updated: 2017-01-23

Condition / research focus: Low Ovarian Reserve
Sponsor: Sun Yat-sen University
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-03. Completion: 2020-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Growth Hormone (drug) — also listed as: somatotropin;GH;somatotrophin;somatotropic

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis

ClinicalTrials.gov · NCT02470169 · Registry updated: 2017-01-23

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Choriomon (drug)
shepherd catheter (device)
Ovulation detection (procedure)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure

ClinicalTrials.gov · NCT02487940 · Registry updated: 2016-12-29

Condition / research focus: Subfertility
Sponsor: Dar El Teb Institute
Countries with listed sites: No country reported
Registry dates and results: Start: 2012-10. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intralipid 20% (drug) — also listed as: Lipofundin 20%
Normal saline (drug) — also listed as: Solution of sodium chloride

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)

ClinicalTrials.gov · NCT00782418 · Registry updated: 2016-12-21

Condition / research focus: The Methodology Assessment of Glucose Dependent Insulin Secretion
Sponsor: Merck Sharp & Dohme LLC
Countries with listed sites: No country reported
Registry dates and results: Start: 2008-09. Completion: 2009-03 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Comparator: exenatide (drug) — also listed as: Byetta
Comparator: exenatide (drug) — also listed as: Byetta
Comparator: Placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

ClinicalTrials.gov · NCT02825290 · Registry updated: 2016-12-13

Condition / research focus: Embryo Transfer; Luteal Support
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-07. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriogonadotropin alfa (drug) — also listed as: recombinant hCG, Ovitrelle, Ovidrel
Triptorelin acetate (drug) — also listed as: GnRH-Agonist, Decapeptyl

Where the study takes place — 1 listed sites

Sheba medical center
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of SNP of GnRH Receptor Genes in IVF Patients

ClinicalTrials.gov · NCT02979886 · Registry updated: 2016-12-05

Condition / research focus: Infertility, Female
Sponsor: Miao benyu
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH-a (drug) — also listed as: triptorelin
Human Menopausal Gonadotropins (drug) — also listed as: menopur

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS

ClinicalTrials.gov · NCT02801565 · Registry updated: 2016-11-28

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2016-02. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Conventional controlled ovarian stimulation proctol (drug)

Where the study takes place — 1 listed sites

Peking University Third Hospital
Beijing, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Serum VEGF as a Tubal Pregnancy Marker

ClinicalTrials.gov · NCT02973230 · Registry updated: 2016-11-25

Condition / research focus: Pregnancy, Ectopic
Sponsor: University of Sao Paulo General Hospital
Countries with listed sites: Brazil
Registry dates and results: Start: 2006-10. Completion: 2007-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dosage of VEGF serum concentration (other)

Where the study takes place — 1 listed sites

University of Sao Paulo - School of Medicine - General Hospital
São Paulo, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

A Study Select Top-grade Embryo by Time-lapse Imaging

ClinicalTrials.gov · NCT02965222 · Registry updated: 2016-11-16

Condition / research focus: Top-grade Embryo
Sponsor: Shanghai First Maternity and Infant Hospital
Countries with listed sites: China
Registry dates and results: Start: 2016-12. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

the time-lapse videography (device)

Where the study takes place — 1 listed sites

Shanghai first Maternity and Infant health hospital, Tong Ji University
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-Up

ClinicalTrials.gov · NCT02299401 · Registry updated: 2016-11-03

Condition / research focus: Pregnancy
Sponsor: Gynuity Health Projects
Countries with listed sites: Bolivia · Ecuador
Registry dates and results: Start: 2014-12. Completion: 2016-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug)
Semi-quantitative pregnancy test (device) — also listed as: SQPT

Where the study takes place — 2 listed sites

Reproductive Health Clinic
La Paz, Pedro Domingo Murillo, Bolivia
Site recruitment: Not reported
Reproductive Health Clinic
Quito, Ecuador
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Endometrial Receptivity After GnRH Agonist Triggering

ClinicalTrials.gov · NCT01500863 · Registry updated: 2016-10-26

Condition / research focus: Ovarian Hyperstimulation Syndrome
Sponsor: IVI Madrid
Countries with listed sites: Spain
Registry dates and results: Start: 2011-11. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug)
triptorelin (drug)
Triptorelin, estradiol valerate, micronized vaginal progesterone (drug)
triptorelin, hCG (drug)
triptorelin, hCG (drug)
triptorelin, recombinant LH (drug)

Where the study takes place — 1 listed sites

Instituto Valenciano de Infertilidad
Madrid, Madrid, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

ClinicalTrials.gov · NCT02940535 · Registry updated: 2016-10-21

Condition / research focus: Subfertility, Female; Ovulation Disorder
Sponsor: Navy General Hospital, Beijing
Countries with listed sites: China
Registry dates and results: Start: 2016-12. Completion: 2020-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Diphereline (Triptorelin embonate) (drug)
Decapeptyl (Triptorelin) (drug)
human menopausal gonadotropin (drug)
human chorionic gonadotropin (drug)

Where the study takes place — 1 listed sites

Navy General Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Treatment With Apremilast in Patients With Psoriatic Arthritis

ClinicalTrials.gov · NCT02558361 · Registry updated: 2016-10-21

Condition / research focus: Psoriatic Arthritis
Sponsor: University of South Florida
Countries with listed sites: United States
Registry dates and results: Start: 2016-04. Completion: 2016-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Treatment with Apremilast (drug) — also listed as: Otezla

Where the study takes place — 1 listed sites

Morsani Center for Advanced healthcare
Tampa, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?

ClinicalTrials.gov · NCT02371486 · Registry updated: 2016-10-14

Condition / research focus: Infertility; Complications; Cesarean Section
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-04. Completion: 2018-02 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hysteroscopic repair of cesarean section defect (procedure) — also listed as: hysteroscopic metroplasty, niche repair
Diagnostic Hysteroscopy (procedure)
Ultrasound Scan (procedure) — also listed as: Internal ultrasound
IVF Cycle (procedure) — also listed as: IVF Treatment

Where the study takes place — 1 listed sites

The chaim sheba medical center,Tel Hashomer
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3WithdrawnINTERVENTIONAL

Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial

ClinicalTrials.gov · NCT02468258 · Registry updated: 2016-09-20

Condition / research focus: Infertility
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-01. Completion: 2017-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

endometrial flushing (procedure)

Where the study takes place — 1 listed sites

Banha Universty
Banhā, El Qalubia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:13 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2 / Phase 3CompletedINTERVENTIONAL

Calcium Dobesilate Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome

ClinicalTrials.gov · NCT02271360 · Registry updated: 2017-02-16

Condition / research focus: Infertility
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-04. Completion: 2015-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Dobesilate (drug) — also listed as: doxium
Cabergoline (drug) — also listed as: Dostinex

Where the study takes place — 1 listed sites

Benha univesity hospital
Banhā, El Qualyobia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Calcium Dobesilate Versus Coasting for Prevention of Ovarian Hyperstimulation Syndrome

ClinicalTrials.gov · NCT02290002 · Registry updated: 2017-02-14

Condition / research focus: Infertility
Sponsor: khalid abd aziz mohamed
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-06. Completion: 2016-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Calcium Dobesilate (drug) — also listed as: doxium
coasting (other)

Where the study takes place — 1 listed sites

Benha univesity hospital
Banhā, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Human Chorionic Gonadotrophin & Trigger

ClinicalTrials.gov · NCT02264847 · Registry updated: 2017-02-08

Condition / research focus: Ovulation Disorder
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2014-10. Completion: 2017-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human chorionic gonadotrophin (drug) — also listed as: hCG
clomiphene citrate alone (drug)

Where the study takes place — 1 listed sites

faculty of medicine , Cairo University
Cairo, Cairo Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Timing Progesterone Luteal Support on Embryo Transfer

ClinicalTrials.gov · NCT03040830 · Registry updated: 2017-02-02

Condition / research focus: Progesterone Luteal Support in ICSI; Embryo Transfer
Sponsor: Mansoura Integrated Fertility Center
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-11-01. Completion: 2017-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Progesterone 100 IM/day (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies

ClinicalTrials.gov · NCT01608347 · Registry updated: 2017-01-24

Condition / research focus: Recurrent Miscarriage
Sponsor: Omar Mamdouh Shaaban
Countries with listed sites: No country reported
Registry dates and results: Start: 2010-01. Completion: 2012-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

LMWH+Folic acid (drug) — also listed as: (Clexane, Sanofi Aventis, Paris, France)
Folic Acid (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effect of Growth Hormone in Assisted Reproductive Technology Clinical Outcome of Poor Responder

ClinicalTrials.gov · NCT03027843 · Registry updated: 2017-01-23

Condition / research focus: Low Ovarian Reserve
Sponsor: Sun Yat-sen University
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-03. Completion: 2020-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Growth Hormone (drug) — also listed as: somatotropin;GH;somatotrophin;somatotropic

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Women With Endometriosis

ClinicalTrials.gov · NCT02470169 · Registry updated: 2017-01-23

Condition / research focus: Subfertility
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-06. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (5)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Merional (drug)
IUI (procedure)
Choriomon (drug)
shepherd catheter (device)
Ovulation detection (procedure)

Where the study takes place — 2 listed sites

BeniSuef University hospitals
BeniSuef, Egypt
Site recruitment: Recruiting
Cairo university hospitals
Cairo, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure

ClinicalTrials.gov · NCT02487940 · Registry updated: 2016-12-29

Condition / research focus: Subfertility
Sponsor: Dar El Teb Institute
Countries with listed sites: No country reported
Registry dates and results: Start: 2012-10. Completion: 2015-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intralipid 20% (drug) — also listed as: Lipofundin 20%
Normal saline (drug) — also listed as: Solution of sodium chloride

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)

ClinicalTrials.gov · NCT00782418 · Registry updated: 2016-12-21

Condition / research focus: The Methodology Assessment of Glucose Dependent Insulin Secretion
Sponsor: Merck Sharp & Dohme LLC
Countries with listed sites: No country reported
Registry dates and results: Start: 2008-09. Completion: 2009-03 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Comparator: exenatide (drug) — also listed as: Byetta
Comparator: exenatide (drug) — also listed as: Byetta
Comparator: Placebo (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

ClinicalTrials.gov · NCT02825290 · Registry updated: 2016-12-13

Condition / research focus: Embryo Transfer; Luteal Support
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-07. Completion: 2017-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriogonadotropin alfa (drug) — also listed as: recombinant hCG, Ovitrelle, Ovidrel
Triptorelin acetate (drug) — also listed as: GnRH-Agonist, Decapeptyl

Where the study takes place — 1 listed sites

Sheba medical center
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Effects of SNP of GnRH Receptor Genes in IVF Patients

ClinicalTrials.gov · NCT02979886 · Registry updated: 2016-12-05

Condition / research focus: Infertility, Female
Sponsor: Miao benyu
Countries with listed sites: No country reported
Registry dates and results: Start: 2017-01. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH-a (drug) — also listed as: triptorelin
Human Menopausal Gonadotropins (drug) — also listed as: menopur

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Clinical Observation of Recombinant Human Growth Hormone Injection Assisted IVF-ET in the Treatment of PCOS

ClinicalTrials.gov · NCT02801565 · Registry updated: 2016-11-28

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2016-02. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Conventional controlled ovarian stimulation proctol (drug)

Where the study takes place — 1 listed sites

Peking University Third Hospital
Beijing, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Serum VEGF as a Tubal Pregnancy Marker

ClinicalTrials.gov · NCT02973230 · Registry updated: 2016-11-25

Condition / research focus: Pregnancy, Ectopic
Sponsor: University of Sao Paulo General Hospital
Countries with listed sites: Brazil
Registry dates and results: Start: 2006-10. Completion: 2007-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Dosage of VEGF serum concentration (other)

Where the study takes place — 1 listed sites

University of Sao Paulo - School of Medicine - General Hospital
São Paulo, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

A Study Select Top-grade Embryo by Time-lapse Imaging

ClinicalTrials.gov · NCT02965222 · Registry updated: 2016-11-16

Condition / research focus: Top-grade Embryo
Sponsor: Shanghai First Maternity and Infant Hospital
Countries with listed sites: China
Registry dates and results: Start: 2016-12. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

the time-lapse videography (device)

Where the study takes place — 1 listed sites

Shanghai first Maternity and Infant health hospital, Tong Ji University
Shanghai, Shanghai Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-Up

ClinicalTrials.gov · NCT02299401 · Registry updated: 2016-11-03

Condition / research focus: Pregnancy
Sponsor: Gynuity Health Projects
Countries with listed sites: Bolivia · Ecuador
Registry dates and results: Start: 2014-12. Completion: 2016-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug)
Semi-quantitative pregnancy test (device) — also listed as: SQPT

Where the study takes place — 2 listed sites

Reproductive Health Clinic
La Paz, Pedro Domingo Murillo, Bolivia
Site recruitment: Not reported
Reproductive Health Clinic
Quito, Ecuador
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Endometrial Receptivity After GnRH Agonist Triggering

ClinicalTrials.gov · NCT01500863 · Registry updated: 2016-10-26

Condition / research focus: Ovarian Hyperstimulation Syndrome
Sponsor: IVI Madrid
Countries with listed sites: Spain
Registry dates and results: Start: 2011-11. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hCG (drug)
triptorelin (drug)
Triptorelin, estradiol valerate, micronized vaginal progesterone (drug)
triptorelin, hCG (drug)
triptorelin, hCG (drug)
triptorelin, recombinant LH (drug)

Where the study takes place — 1 listed sites

Instituto Valenciano de Infertilidad
Madrid, Madrid, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

ClinicalTrials.gov · NCT02940535 · Registry updated: 2016-10-21

Condition / research focus: Subfertility, Female; Ovulation Disorder
Sponsor: Navy General Hospital, Beijing
Countries with listed sites: China
Registry dates and results: Start: 2016-12. Completion: 2020-12 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Diphereline (Triptorelin embonate) (drug)
Decapeptyl (Triptorelin) (drug)
human menopausal gonadotropin (drug)
human chorionic gonadotropin (drug)

Where the study takes place — 1 listed sites

Navy General Hospital
Beijing, Beijing Municipality, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4WithdrawnINTERVENTIONAL

Treatment With Apremilast in Patients With Psoriatic Arthritis

ClinicalTrials.gov · NCT02558361 · Registry updated: 2016-10-21

Condition / research focus: Psoriatic Arthritis
Sponsor: University of South Florida
Countries with listed sites: United States
Registry dates and results: Start: 2016-04. Completion: 2016-10 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Treatment with Apremilast (drug) — also listed as: Otezla

Where the study takes place — 1 listed sites

Morsani Center for Advanced healthcare
Tampa, Florida, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Does Cesarean Section Scar Defect (Niche) Affect Implantation Rate?

ClinicalTrials.gov · NCT02371486 · Registry updated: 2016-10-14

Condition / research focus: Infertility; Complications; Cesarean Section
Sponsor: Sheba Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2016-04. Completion: 2018-02 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

hysteroscopic repair of cesarean section defect (procedure) — also listed as: hysteroscopic metroplasty, niche repair
Diagnostic Hysteroscopy (procedure)
Ultrasound Scan (procedure) — also listed as: Internal ultrasound
IVF Cycle (procedure) — also listed as: IVF Treatment

Where the study takes place — 1 listed sites

The chaim sheba medical center,Tel Hashomer
Ramat Gan, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2 / Phase 3WithdrawnINTERVENTIONAL

Multi-factorial Analysis of the Follicular Fluid Milieu to Explore the Discrepant Effect of Follicular Fluid Endometrial Flushing on Outcome of Assisted Reproduction Trial

ClinicalTrials.gov · NCT02468258 · Registry updated: 2016-09-20

Condition / research focus: Infertility
Sponsor: Benha University
Countries with listed sites: Egypt
Registry dates and results: Start: 2013-01. Completion: 2017-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

endometrial flushing (procedure)

Where the study takes place — 1 listed sites

Banha Universty
Banhā, El Qalubia, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →